PATENT CLAIM ANALYSIS

Application Number: 15896027
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["424", "185100"]

Abstract:
Prophylactic and/or therapeutic antipathogen agents are provided that disrupt or prevent the formation of at least one homotypic and/or heterotypic protein-protein interaction that has at least one CEA-family protein and that is involved in the establishment and colonization of a pathogen in a suitable host.

Claim (Index 2):
A multimer therapeutic agent comprising an isolated amino acid sequence wherein said amino acid sequence comprises the sequence NRQIV (SEQ ID No. 21) and QNDTG (SEQ ID No. 23).

Metadata:
- Claim Count in Document: 5.0
- Percentile: 88.0
- Lexical Diversity: 1.31429
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11679657', '13628541', '15176950', '11097749', '15604153']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.686859929254424
- 35 USC 102 Novelty (BERT): 0.5421269087096954
- Combined Prediction Score: 0.6723866271999511
- Mean Citation Score: 296.55228
- Max Citation Score: 376.0656
- Similarity Product: 286.8701388765336

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test